COMPOSITION
Flumeglin Injectable Solution is a colorless and clear solution. Each ml contains flunixin meglumine equivalent to 50 mg of flunixin base.
INDICATIONS FOR USE
Flumeglin Injectable Solution is a non-steroidal anti-inflammatory drug with antipyretic, analgesic and non-narcotic efficacy. It is mainly used for the alleviation of inflammation and pain associated with colic in horses, for the control of acute inflammation associated with infectious diseases in cattle. Additionally, in cattle, horses and dogs;
- In the treatment of pain and inflammation associated with tendon and musculoskeletal disorders, and pain associated with spasms of smooth muscles of internal organs.
- It decreases the amount of lactic acid in blood and tissues and inhibits the decrease of blood pressure, increases the venous return of blood to the heart, reduces the damage in vascular endothelial cells.
- For the control of acute inflammations associated with colibacillosis, pneumonia and chronic obstructive respiratory diseases, and also as an adjuvant in the treatment of acute bovine pulmonary emphysema (fog fever) and acute mastitis.
ADMINISTRATION ROUTES AND AMOUNTS
Flumeglin Injectable Solution is administered via slow intravenous (IV) or intramuscular (IM) injection depending on the animal species, as shown in the table, unless recommended otherwise by the veterinarian.
For the treatment of Equine colic, colitis and endotoxic shock in horses, administer intravenously (IV) at the dose of 1.1 mg/kg bw / day (1 ml / 45 kg bw / day), and repeat if necessary.
WITHDRAWAL PERIOD(S)
Animals should not be slaughtered during the treatment and for 21 days following the last treatment. Cow milk should not be used for human consumption during the treatment and for 5 days (10 milkings) following the last treatment.
MARKETING PACKAGING
Sold as 50 ml, 100 ml and 250 ml in amber colored glass vials inside cardboard boxes.
